Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

Mark K. Meiselbach; Ge Bai; Gerard F. Anderson

doi:10.1007/s11606-020-06198-y

Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

Mark K. Meiselbach, Ge Bai, Gerard F. Anderson

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	3640-3643
Number of pages	4
Journal	Journal of general internal medicine
Volume	38
Issue number	16
DOIs	https://doi.org/10.1007/s11606-020-06198-y
State	Published - Dec 2023

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1007/s11606-020-06198-y

Cite this

@article{da0b350b15fb423a9910efaf59d0b03d,

title = "Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States",

author = "Meiselbach, {Mark K.} and Ge Bai and Anderson, {Gerard F.}",

note = "Funding Information: All authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article. Mark K. Meiselbach is supported by the T32HS000029 grant from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The data, technology, and services used in the generation of these research findings were generously supplied pro bono by the COVID-19 Research Database partners, who are acknowledged at www.covid19researchdatabase.org . This study is funded by Arnold Ventures. ",

year = "2023",

month = dec,

doi = "10.1007/s11606-020-06198-y",

language = "English (US)",

volume = "38",

pages = "3640--3643",

journal = "Journal of general internal medicine",

issn = "0884-8734",

publisher = "Springer New York",

number = "16",

}

TY - JOUR

T1 - Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

AU - Meiselbach, Mark K.

AU - Bai, Ge

AU - Anderson, Gerard F.

N1 - Funding Information: All authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article. Mark K. Meiselbach is supported by the T32HS000029 grant from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The data, technology, and services used in the generation of these research findings were generously supplied pro bono by the COVID-19 Research Database partners, who are acknowledged at www.covid19researchdatabase.org . This study is funded by Arnold Ventures.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85091075019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091075019&partnerID=8YFLogxK

U2 - 10.1007/s11606-020-06198-y

DO - 10.1007/s11606-020-06198-y

M3 - Letter

C2 - 32935319

AN - SCOPUS:85091075019

SN - 0884-8734

VL - 38

SP - 3640

EP - 3643

JO - Journal of general internal medicine

JF - Journal of general internal medicine

IS - 16

ER -

Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this